730 studies found for:    Uterine Cancer: Clinical Trials
Show Display Options
Rank Status Study
21 Completed
Has Results
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
Conditions: Neoplasms;   Neoplasms by Site;   Urogenital Neoplasms;   Genital Neoplasms, Female;   Uterine Neoplasms;   Endometrial Neoplasms;   Cancer of Endometrium;   Endometrial Cancer;   Cancer of the Endometrium;   Endometrium Cancer;   Neoplasms, Endometrial
Intervention: Drug: pemetrexed
22 Recruiting Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Conditions: Ovarian Cancer;   Cervical Cancer;   Uterine Cancer;   Anemia
Interventions: Other: Oral Ferrous Fumarate;   Other: Placebo
23 Active, not recruiting Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Pulmonary Carcinoid Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Renal Cell Cancer;   Recurrent Uterine Sarcoma;   Stage III Renal Cell Cancer;   Stage IIIB Uterine Sarcoma;   Stage IIIC Uterine Sarcoma;   Stage IV Renal Cell Cancer;   Stage IVA Uterine Sarcoma;   Stage IVB Uterine Sarcoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: trebananib;   Drug: temsirolimus;   Other: pharmacological study;   Other: laboratory biomarker analysis
24 Completed Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Radiation: radiation therapy
25 Enrolling by invitation Improving the Treatment for Women With Early Stage Cancer of the Uterus
Conditions: Complex Endometrial Hyperplasia With Atypia;   Grade 1 Endometrial Endometrioid Adenocarcinoma
Interventions: Drug: Levonorgestrel;   Drug: Metformin
26 Active, not recruiting Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Intervention: Drug: pazopanib hydrochloride
27 Active, not recruiting Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Conditions: Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Uterine Sarcoma;   Stage I Endometrial Carcinoma;   Stage I Uterine Sarcoma;   Stage IA Cervical Cancer;   Stage IB Cervical Cancer;   Stage II Endometrial Carcinoma;   Stage II Uterine Sarcoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage III Uterine Sarcoma;   Stage IV Endometrial Carcinoma;   Stage IV Uterine Sarcoma;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Other: medical chart review;   Other: questionnaire administration
28 Completed Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: imatinib mesylate;   Other: laboratory biomarker analysis
29 Completed The Effect of Nutritional Counseling for Cancer Patients
Conditions: Esophageal Cancer;   Gastric Cancer;   Uterine Cancer
Interventions: Behavioral: Weekly nutritional counseling;   Dietary Supplement: Forticare®.
30 Terminated Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Conditions: Uterine Cervical Cancer;   Endometrial Cancer
Intervention: Drug: Zalypsis ( PM00104)
31 Completed Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease
Condition: Breast Cancer
Interventions: Drug: Raloxifene followed by combination therapy;   Drug: Exemestane followed by combination therapy
32 Recruiting Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: ixabepilone;   Other: laboratory biomarker analysis
33 Recruiting Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
Conditions: Anxiety Disorder;   Worry;   Uncertainty;   Sleep Disorders;   Insomnia;   Fatigue;   Pain;   Depression;   Cognitive-behavioral Therapy;   Psychological Intervention;   Esophageal Cancer;   Pancreatic Cancer;   Leukemia;   Lung Cancer;   Multiple Myeloma;   Ovarian Neoplasm;   Stage III or IV Cervical or Uterine Cancer;   Stage IIIB, IIIC, or IV Breast Cancer;   Glioblastoma Multiforme;   Relapsed Lymphoma;   Stage III or IV Colorectal Cancer;   Stage IIIC or IV Melanoma
Intervention: Behavioral: Cognitive-behavioral therapy for worry, uncertainty & insomnia
34 Completed Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Conditions: Recurrent Uterine Sarcoma;   Uterine Leiomyosarcoma
Interventions: Drug: thalidomide;   Other: laboratory biomarker analysis
35 Active, not recruiting Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma
Intervention: Drug: sorafenib tosylate
36 Withdrawn BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
Condition: Endometrial Cancer
Intervention: Drug: BEZ235
37 Terminated Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
Condition: Sarcoma
Interventions: Biological: sargramostim;   Drug: cisplatin;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: mitomycin C
38 Unknown  Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer
39 Completed Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
Condition: Sarcoma
Interventions: Drug: cisplatin;   Drug: ifosfamide;   Procedure: adjuvant therapy;   Radiation: radiation therapy
40 Completed Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
Condition: Sarcoma
Interventions: Drug: docetaxel;   Drug: gemcitabine hydrochloride

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years